Bulk Acetylsalicylic Acid (Aspirin) from China. Investigation No. 731-TA-828(Final). Determination and Views of the Commission

摘要

On the basis of the record developed in the subject investigation, the UnitedStates International Trade Commission determines, pursuant to section 735(b) of the Tariff Act of 1930 (19 U.S.C. Section 1673d(b)) (the Act), that an industry in the United States is threatened with material injury by reason of imports from China of bulk acetylsalicylic acid (aspirin), provided for in subheadings 2918.22.10 and 3003.90.00 of the Harmonized Tariff Schedule of the United States, that have been found by the Department of Commerce to be sold in the United States at less than fair value (LTFV). The Commission further determines that it wseases. Past publications included information on selected non-notifiable diseases, but this year's Summary presents only highlights of nationally notifiable diseases. Part 1 contains tables that present incidence data for each of the diseases considered nationally notifiable during 1999. The tables provide the number of cases of notifiable diseases reported to CDC for 1999, as well as the distribution of cases by month and geographic location and by patients age, sex, race, and Hispanic ethnicity. The data are final totals as of August 15, 2000, unless otherwise noted. In all tables, leprosy is listed as Hansen disease, and tickborne typhus fever is listed as Rocky Mountain spotted fever (RMSF). Part 2 contains graphs and maps. These graphs and maps depict summary data for many of the notifiable diseases described in tabular form in Part 1. Part 3 contains tables that list the number of cases of notifiable diseases reported to CDC since 1968. This section also includes a table enumerating deaths associated with specified notifiable diseases reported to the National Center for Health Statistics (NCHS), CDC, during 1989-1998.